SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Morgan Stanley Initiates Coverage On Pacific Biosciences with Equal-Weight Rating, Announces Price Target of $7

Morgan Stanley initiates coverage on Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight rating and announces Price Target of $7.

· 09/09/2020 08:16
Morgan Stanley initiates coverage on Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight rating and announces Price Target of $7.